XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles ADTX Q3 2025 Earnings Deepening Losses and Lack of Revenue Highlight Operational Challenges UK Police to Assess Train Operators on Sexual Harassment Prevention No Financial Penalties Imposed UK Service Sector Activity Declines Sharply Perfect Storm of Political Uncertainty and Iran Conflict Weighs on Businesses EU Business Investment Rate Slips to 11Year Low Amid Tariff Pressures Weak Demand and Climate Policy Confusion HMY Q2 2016 Earnings EPS Misses Estimates by Wide Margin Amid Cost Pressures NFL Seeks Ban on Certain Player Prop Bets in Prediction Markets Citing Integrity and Age Concerns